Back

Structure-based design of antisense oligonucleotides that inhibit SARS-CoV-2 replication

Li, Y.; Garcia, G.; Arumugaswami, V.; Guo, F.

2021-08-24 molecular biology
10.1101/2021.08.23.457434 bioRxiv
Show abstract

Antisense oligonucleotides (ASOs) are an emerging class of drugs that target RNAs. Current ASO designs strictly follow the rule of Watson-Crick base pairing along target sequences. However, RNAs often fold into structures that interfere with ASO hybridization. Here we developed a structure-based ASO design method and applied it to target severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our method makes sure that ASO binding is compatible with target structures in three-dimensional (3D) space by employing structural design templates. These 3D-ASOs recognize the shapes and hydrogen bonding patterns of targets via tertiary interactions, achieving enhanced affinity and specificity. We designed 3D-ASOs that bind to the frameshift stimulation element and transcription regulatory sequence of SARS-CoV-2 and identified lead ASOs that strongly inhibit viral replication in human cells. We further optimized the lead sequences and characterized structure-activity relationship. The 3D-ASO technology helps fight coronavirus disease-2019 and is broadly applicable to ASO drug development.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 3%
30.7%
Similar papers in this journal
2
Molecular Cell
○ 350 papers in training set
Top 0.7%
7.8%
Similar papers in this journal
3
Nucleic Acids Research
◐ 1281 papers in training set
Top 2%
7.8%
Similar papers in this journal
4
Cell Reports
○ 1498 papers in training set
Top 7%
5.4%
Similar papers in this journal
50% of probability mass above
5
Nature Structural & Molecular Biology
236 papers in training set
Top 1%
3.2%
6
Cell
○ 431 papers in training set
Top 3%
3.2%
Similar papers in this journal
7
Science
● 477 papers in training set
Top 3%
3.2%
8
Cell Chemical Biology
○ 94 papers in training set
Top 0.4%
3.1%
9
Journal of the American Chemical Society
● 217 papers in training set
Top 2%
2.1%
10
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 24%
2.1%
11
Angewandte Chemie International Edition
○ 93 papers in training set
Top 0.8%
1.9%
12
Science Advances
● 1243 papers in training set
Top 18%
1.9%
13
eLife
● 5828 papers in training set
Top 51%
1.7%
14
Molecular Therapy
○ 81 papers in training set
Top 0.9%
1.7%
15
Nature
○ 645 papers in training set
Top 7%
1.5%
16
Nature Chemical Biology
○ 119 papers in training set
Top 2%
1.3%
17
Cell Discovery
○ 57 papers in training set
Top 0.6%
1.3%
18
ACS Central Science
● 71 papers in training set
Top 0.9%
1.3%
19
Protein & Cell
◐ 25 papers in training set
Top 0.3%
1.1%
20
ACS Chemical Biology
● 167 papers in training set
Top 2%
1.1%
21
Molecular Therapy Nucleic Acids
○ 39 papers in training set
Top 0.7%
1.0%
22
Communications Biology
○ 993 papers in training set
Top 28%
0.9%
23
Nature Biotechnology
○ 172 papers in training set
Top 4%
0.9%
24
Nature Methods
○ 385 papers in training set
Top 7%
0.8%
25
iScience
○ 1154 papers in training set
Top 37%
0.8%
26
Cell Systems
○ 201 papers in training set
Top 5%
0.6%
27
RNA
● 189 papers in training set
Top 2%
0.6%
28
The EMBO Journal
○ 309 papers in training set
Top 8%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.